Journal of Nuclear Medicine Vol. 45 No. 8 8A-9A
© 2004 by Society of Nuclear Medicine
THIS MONTH IN JNM
Buck and colleagues assess published reports suggesting that, in addition to its utility in staging and restaging lung cancer, 18F-FDG PET provides significant prognostic information on patients with non-small cell lung cancer.
Page 1274
Scheffel and Pomper look at the promise and potential limitations of current tracers used in PET imaging of gastrin-releasing peptide receptor expression in prostate cancer.
Page 1277
Lemke and colleagues report on incremental diagnostic information provided by retrospective PET/CT image fusion on data from patients with suspected pancreatic lesions.
Page 1279
Erdi and colleagues evaluate the effects of motion and respiratory phase on standardized uptake values in PET/CT of patients with lung cancer.
Page 1287
Pirotte and colleagues compare the merits of 18F-FDG and 11C-methionine as tracers for PET-guided neurosurgical procedures on gliomas.
Page 1293
Knappen and colleagues investigate the advantages of the perfusable tissue index in noninvasive assessment of myocardial fibrosis in patients with idiopathic dilated cardiomyopathy.
Page 1299
Tanabe and colleagues apply 123I-MIBG myocardial scintigraphy to the physiologic assessment of patients with panic disorder and find evidence of impaired cardiac sympathetic function.
Page 1305
Wells and colleagues present results evaluating the utility of dSPECT, an iterative algorithm, in removing bladder artifacts from clinically acquired pelvic bone SPECT images.
Page 1309
Jani and colleagues assess the role of radioimmunoscintigraphy directed against prostate-specific membrane antigen in influencing radiotherapy toxicity and biochemical control after prostatectomy.
Page 1315
Fuster and colleagues compare the accuracy of 18F-FDG PET with that of standard diagnostic clinical procedures in detecting locoregional disease and distant metastases in patients referred for suspected recurrent melanoma.
Page 1323
Sundaram and colleagues describe a simplified kinetic analysis method for dynamic assessment of 18F-FDG uptake in tumor.
Page 1328
Guo and colleagues investigate correlations between 18F-FDG uptake in PET imaging, lactate and choline concentrations measured by in vitro 1H magnetic resonance spectroscopy, and survival in human lung adenocarcinoma.
Page 1334
Bagheri and colleagues describe the additional value of 18F-FDG PET/CT over PET alone in reliable visualization of the normal adrenal gland.
Page 1340
Weber and colleagues evaluate a continuous-infusion H215O PET and acetazolamide challenge protocol as an alternative to single-bolus injection for assessment of cerebral perfusion status in patients with cerebrovascular disease.
Page 1344
Oturai and colleagues compare the diagnostic accuracies of 
-camera PET and dedicated PET in patients with suspected lung cancer.
Page 1351
Pandit-Taskar and colleagues provide a comprehensive review of radiopharmaceuticals currently used for palliation in patients with osseous metastases, including approved dosages, methods of administration, indications for use, and recommended guidelines.
Page 1358
Sgouros and colleagues describe and evaluate 124I PET-based, patient-specific, 3-dimensional dosimetry for 131I therapy in thyroid cancer.
Page 1366
Blankenberg and colleagues propose a novel imaging complex with a radiolabeled adapter protein bound to a docking tag and fused to a targeting protein as a model system for targeted imaging with a variety of protein-based radiotracers.
Page 1373
Thakur and colleagues assess the feasibility of 64Cu-TP3982 PET imaging of oncogene VPAC1 receptors overexpressed in human breast cancer cells.
Page 1381
Chen and colleagues use small-animal PET and autoradiographic imaging in prostate cancer-xenografted mice to evaluate 64Cu-radiolabeled gastrin-releasing peptide analogs for imaging peptide receptor expression.
Page 1390
Toyama and colleagues report on the use of 18F-FDG and small-animal PET for investigating the feasibility of absolute quantification of regional cerebral glucose use in a mouse model.
Page 1398
Koort and colleagues describe a laboratory study comparing the 18F-FDG PET characteristics of normal bone healing with those of local osteomyelitis and evaluating the ability of PET to differentiate bone healing from local infection.
Page 1406
Divgi and colleagues determine the maximum tolerated whole-body radiation-absorbed dose for a 131I-labeled fractionated radioimmunotherapy used for metastatic renal cancer.
Page 1412
| ON THE COVER
This image depicts localization of 64Cu-DOTA-Lys3-bombesin in PC-3 and CWR22 tumor-bearing mice as determined by microPET imaging (Concorde Microsystems, Inc.) followed by whole-body autoradiography. The microPET image is concordant with the whole-body autoradiographic section. Both the PC-3 tumor and the CWR22 tumor are visible, with clear contrast from the adjacent background. Prominent uptake is also seen in the liver and kidneys, and clearance of activity through the urinary bladder is evident.
|
Related articles in JNM:
- Quantification of 18F-FDG Uptake in Non–Small Cell Lung Cancer: A Feasible Prognostic Marker?
- Andreas K. Buck, Gerhard Glatting, and Sven N. Reske
JNM 2004 45: 1274-1276.
[Full Text]
- PET Imaging of GRP Receptor Expression in Prostate Cancer
- Ursula Scheffel and Martin G. Pomper
JNM 2004 45: 1277-1278.
[Full Text]
- Retrospective Digital Image Fusion of Multidetector CT and 18F-FDG PET: Clinical Value in Pancreatic Lesions—A Prospective Study with 104 Patients
- Arne-Jörn Lemke, Stefan Markus Niehues, Norbert Hosten, Holger Amthauer, Michael Boehmig, Christian Stroszczynski, Torsten Rohlfing, Stefan Rosewicz, and Roland Felix
JNM 2004 45: 1279-1286.
[Abstract]
[Full Text]
- The CT Motion Quantitation of Lung Lesions and Its Impact on PET-Measured SUVs
- Yusuf E. Erdi, Sadek A. Nehmeh, Tinsu Pan, Alexander Pevsner, Kenneth E. Rosenzweig, Gikas Mageras, Ellen D. Yorke, Heiko Schoder, Wendy Hsiao, Olivia D. Squire, Phil Vernon, Jonathan B. Ashman, Hassan Mostafavi, Steven M. Larson, and John L. Humm
JNM 2004 45: 1287-1292.
[Abstract]
[Full Text]
- Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of Gliomas
- Benoit Pirotte, Serge Goldman, Nicolas Massager, Philippe David, David Wikler, Arlette Vandesteene, Isabelle Salmon, Jacques Brotchi, and Marc Levivier
JNM 2004 45: 1293-1298.
[Abstract]
[Full Text]
- Perfusable Tissue Index as a Potential Marker of Fibrosis in Patients with Idiopathic Dilated Cardiomyopathy
- Paul Knaapen, Ronald Boellaard, Marco J.W. Götte, Pieter A. Dijkmans, Linda M.C. van Campen, Carel C. de Cock, Gert Luurtsema, Cees A. Visser, Adriaan A. Lammertsma, and Frans C. Visser
JNM 2004 45: 1299-1304.
[Abstract]
[Full Text]
- 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Panic Disorder
- Yoshio Tanabe, Hiromi Harada, Shuji Sugihara, Toshihide Ogawa, and Yuichi Inoue
JNM 2004 45: 1305-1308.
[Abstract]
[Full Text]
- Reducing Bladder Artifacts in Clinical Pelvic SPECT Images
- R. Glenn Wells, Troy Farncombe, Edward Chang, and R. Larry Nicholson
JNM 2004 45: 1309-1314.
[Abstract]
[Full Text]
- Radioimmunoscintigraphy for Postprostatectomy Radiotherapy: Analysis of Toxicity and Biochemical Control
- Ashesh B. Jani, Michael J. Blend, Russell Hamilton, Charles Brendler, Charles Pelizzari, Lani Krauz, Bipin Sapra, Srinivasan Vijayakumar, Azhar Awan, and Ralph R. Weichselbaum
JNM 2004 45: 1315-1322.
[Abstract]
[Full Text]
- Is 18F-FDG PET More Accurate Than Standard Diagnostic Procedures in the Detection of Suspected Recurrent Melanoma?
- David Fuster, Stephen Chiang, Germaine Johnson, Lynn M. Schuchter, Hongming Zhuang, and Abass Alavi
JNM 2004 45: 1323-1327.
[Abstract]
[Full Text]
- Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach
- Senthil K. Sundaram, Nanette M.T. Freedman, Jorge A. Carrasquillo, Joann M. Carson, Millie Whatley, Steven K. Libutti, David Sellers, and Stephen L. Bacharach
JNM 2004 45: 1328-1333.
[Abstract]
[Full Text]
- In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma
- JianFei Guo, Kotaro Higashi, Hajime Yokota, Yosinobu Nagao, Yoshimichi Ueda, Yuko Kodama, Manabu Oguchi, Suzuka Taki, Hisao Tonami, and Itaru Yamamoto
JNM 2004 45: 1334-1339.
[Abstract]
[Full Text]
- Characterization of the Normal Adrenal Gland with 18F-FDG PET/CT
- Baharak Bagheri, Alan H. Maurer, Libby Cone, Mohan Doss, and Lee Adler
JNM 2004 45: 1340-1343.
[Abstract]
[Full Text]
- Constant-Infusion H215O PET and Acetazolamide Challenge in the Assessment of Cerebral Perfusion Status
- Bruno Weber, Gerrit Westera, Valerie Treyer, Cyrill Burger, Nadia Khan, and Alfred Buck
JNM 2004 45: 1344-1350.
[Abstract]
[Full Text]
- -Camera 18F-FDG PET in Diagnosis and Staging of Patients Presenting with Suspected Lung Cancer and Comparison with Dedicated PET
- Peter S. Oturai, Jann Mortensen, Henriette Enevoldsen, Annika Eigtved, Vibeke Backer, Knud P. Olesen, Henrik W. Nielsen, Hanne Hansen, Poul Stentoft, and Lars Friberg
JNM 2004 45: 1351-1357.
[Abstract]
[Full Text]
- Radiopharmaceutical Therapy for Palliation of Bone Pain from Osseous Metastases
- Neeta Pandit-Taskar, Maria Batraki, and Chaitanya R. Divgi
JNM 2004 45: 1358-1365.
[Abstract]
[Full Text]
- Patient-Specific Dosimetry for 131I Thyroid Cancer Therapy Using 124I PET and 3-Dimensional-Internal Dosimetry (3D-ID) Software
- George Sgouros, Katherine S. Kolbert, Arif Sheikh, Keith S. Pentlow, Edward F. Mun, Axel Barth, Richard J. Robbins, and Steven M. Larson
JNM 2004 45: 1366-1372.
[Abstract]
[Full Text]
- Tumor Imaging Using a Standardized Radiolabeled Adapter Protein Docked to Vascular Endothelial Growth Factor
- Francis G. Blankenberg, Stefanie Mandl, Yu-An Cao, Caitlin O’Connell-Rodwell, Christopher Contag, Carina Mari, Timur I. Gaynutdinov, Jean-Luc Vanderheyden, Marina V. Backer, and Joseph M. Backer
JNM 2004 45: 1373-1380.
[Abstract]
[Full Text]
- PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
- Mathew L. Thakur, Mohan R. Aruva, Jean Gariepy, Paul Acton, Satish Rattan, Shyam Prasad, Eric Wickstrom, and Abass Alavi
JNM 2004 45: 1381-1389.
[Abstract]
[Full Text]
- microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts
- Xiaoyuan Chen, Ryan Park, Yingping Hou, Michel Tohme, Antranik H. Shahinian, James R. Bading, and Peter S. Conti
JNM 2004 45: 1390-1397.
[Abstract]
[Full Text]
- Absolute Quantification of Regional Cerebral Glucose Utilization in Mice by 18F-FDG Small Animal PET Scanning and 2-14C-DG Autoradiography
- Hiroshi Toyama, Masanori Ichise, Jeih-San Liow, Kendra J. Modell, Douglass C. Vines, Takanori Esaki, Michelle Cook, Jurgen Seidel, Louis Sokoloff, Michael V. Green, and Robert B. Innis
JNM 2004 45: 1398-1405.
[Abstract]
[Full Text]
- Comparative 18F-FDG PET of Experimental Staphylococcus aureus Osteomyelitis and Normal Bone Healing
- Jyri K. Koort, Tatu J. Mäkinen, Juhani Knuuti, Jari Jalava, and Hannu T. Aro
JNM 2004 45: 1406-1411.
[Abstract]
[Full Text]
- Phase I Clinical Trial with Fractionated Radioimmunotherapy Using 131I-Labeled Chimeric G250 in Metastatic Renal Cancer
- Chaitanya R. Divgi, Joseph A. O’Donoghue, Sydney Welt, Jayne O’Neel, Ron Finn, Robert J. Motzer, Achim Jungbluth, Eric Hoffman, Gerd Ritter, Steve M. Larson, and Lloyd J. Old
JNM 2004 45: 1412-1421.
[Abstract]
[Full Text]
